3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-cyclopenta[b]pyridine;N,N-dimethyl-3-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)benzenesulfonamide;methane;1-[6-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)pyrazin-2-yl]pyrrolidin-2-one;5-methyl-3-[6-[(1-methylazetidin-3-yl)methyl]pyrazin-2-yl]-7H-cyclopenta[b]pyridine;5-methyl-3-(3-pyrrolidin-1-ylpyrazin-2-yl)-7H-cyclopenta[b]pyridine

C92H98N18O3S — CID 158465638

IUPAC3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-cyclopenta[b]pyridine;N,N-dimethyl-3-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)benzenesulfonamide;methane;1-[6-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)pyrazin-2-yl]pyrrolidin-2-one;5-methyl-3-[6-[(1-methylazetidin-3-yl)methyl]pyrazin-2-yl]-7H-cyclopenta[b]pyridine;5-methyl-3-(3-pyrrolidin-1-ylpyrazin-2-yl)-7H-cyclopenta[b]pyridine
SMILESC.C.CC1=CCc2ncc(-c3cccc(S(=O)(=O)N(C)C)c3)cc21.CC1=CCc2ncc(-c3cncc(CC4CN(C)C4)n3)cc21.CC1=CCc2ncc(-c3cncc(N4CCCC4=O)n3)cc21.CC1=CCc2ncc(-c3cncc(N4CCc5ccccc54)n3)cc21.CC1=CCc2ncc(-c3nccnc3N3CCCC3)cc21
InChIInChI=1S/C21H18N4.C18H20N4.C17H16N4O.C17H18N4.C17H18N2O2S.2CH4/c1-14-6-7-18-17(14)10-16(11-23-18)19-12-22-13-21(24-19)25-9-8-15-4-2-3-5-20(15)25;1-12-3-4-17-16(12)6-14(7-20-17)18-9-19-8-15(21-18)5-13-10-22(2)11-13;1-11-4-5-14-13(11)7-12(8-19-14)15-9-18-10-16(20-15)21-6-2-3-17(21)22;1-12-4-5-15-14(12)10-13(11-20-15)16-17(19-7-6-18-16)21-8-2-3-9-21;1-12-7-8-17-16(12)10-14(11-18-17)13-5-4-6-15(9-13)22(20,21)19(2)3;;/h2-6,10-13H,7-9H2,1H3;3,6-9,13H,4-5,10-11H2,1-2H3;4,7-10H,2-3,5-6H2,1H3;4,6-7,10-11H,2-3,5,8-9H2,1H3;4-7,9-11H,8H2,1-3H3;2*1H4
InChIKeyHFSHSDBNAGWAPJ-UHFFFAOYSA-N
MW1535.99 g/mol
LogP16.75
Rot. Bonds12

About 3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-cyclopenta[b]pyridine;N,N-dimethyl-3-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)benzenesulfonamide;methane;1-[6-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)pyrazin-2-yl]pyrrolidin-2-one;5-methyl-3-[6-[(1-methylazetidin-3-yl)methyl]pyrazin-2-yl]-7H-cyclopenta[b]pyridine;5-methyl-3-(3-pyrrolidin-1-ylpyrazin-2-yl)-7H-cyclopenta[b]pyridine

3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-cyclopenta[b]pyridine;N,N-dimethyl-3-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)benzenesulfonamide;methane;1-[6-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)pyrazin-2-yl]pyrrolidin-2-one;5-methyl-3-[6-[(1-methylazetidin-3-yl)methyl]pyrazin-2-yl]-7H-cyclopenta[b]pyridine;5-methyl-3-(3-pyrrolidin-1-ylpyrazin-2-yl)-7H-cyclopenta[b]pyridine (PubChem CID 158465638) has the molecular formula C92H98N18O3S and a molecular weight of 1535.99 g/mol. Its IUPAC name is 3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-cyclopenta[b]pyridine;N,N-dimethyl-3-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)benzenesulfonamide;methane;1-[6-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)pyrazin-2-yl]pyrrolidin-2-one;5-methyl-3-[6-[(1-methylazetidin-3-yl)methyl]pyrazin-2-yl]-7H-cyclopenta[b]pyridine;5-methyl-3-(3-pyrrolidin-1-ylpyrazin-2-yl)-7H-cyclopenta[b]pyridine.

Molecular Properties

Compound Name3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-cyclopenta[b]pyridine;N,N-dimethyl-3-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)benzenesulfonamide;methane;1-[6-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)pyrazin-2-yl]pyrrolidin-2-one;5-methyl-3-[6-[(1-methylazetidin-3-yl)methyl]pyrazin-2-yl]-7H-cyclopenta[b]pyridine;5-methyl-3-(3-pyrrolidin-1-ylpyrazin-2-yl)-7H-cyclopenta[b]pyridine
PubChem CID158465638
Molecular FormulaC92H98N18O3S
Molecular Weight1535.99 g/mol
Exact Mass1534.78
IUPAC Name3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-cyclopenta[b]pyridine;N,N-dimethyl-3-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)benzenesulfonamide;methane;1-[6-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)pyrazin-2-yl]pyrrolidin-2-one;5-methyl-3-[6-[(1-methylazetidin-3-yl)methyl]pyrazin-2-yl]-7H-cyclopenta[b]pyridine;5-methyl-3-(3-pyrrolidin-1-ylpyrazin-2-yl)-7H-cyclopenta[b]pyridine
SMILESC.C.CC1=CCc2ncc(-c3cccc(S(=O)(=O)N(C)C)c3)cc21.CC1=CCc2ncc(-c3cncc(CC4CN(C)C4)n3)cc21.CC1=CCc2ncc(-c3cncc(N4CCCC4=O)n3)cc21.CC1=CCc2ncc(-c3cncc(N4CCc5ccccc54)n3)cc21.CC1=CCc2ncc(-c3nccnc3N3CCCC3)cc21
InChIInChI=1S/C21H18N4.C18H20N4.C17H16N4O.C17H18N4.C17H18N2O2S.2CH4/c1-14-6-7-18-17(14)10-16(11-23-18)19-12-22-13-21(24-19)25-9-8-15-4-2-3-5-20(15)25;1-12-3-4-17-16(12)6-14(7-20-17)18-9-19-8-15(21-18)5-13-10-22(2)11-13;1-11-4-5-14-13(11)7-12(8-19-14)15-9-18-10-16(20-15)21-6-2-3-17(21)22;1-12-4-5-15-14(12)10-13(11-20-15)16-17(19-7-6-18-16)21-8-2-3-9-21;1-12-7-8-17-16(12)10-14(11-18-17)13-5-4-6-15(9-13)22(20,21)19(2)3;;/h2-6,10-13H,7-9H2,1H3;3,6-9,13H,4-5,10-11H2,1-2H3;4,7-10H,2-3,5-6H2,1H3;4,6-7,10-11H,2-3,5,8-9H2,1H3;4-7,9-11H,8H2,1-3H3;2*1H4
InChIKeyHFSHSDBNAGWAPJ-UHFFFAOYSA-N
XLogP16.75
TPSA234.98 Ų
H-Bond Donors
H-Bond Acceptors19
Rotatable Bonds12
Heavy Atoms114
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001535.99
LogP ≤ 516.75
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1019

Analyze 3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-cyclopenta[b]pyridine;N,N-dimethyl-3-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)benzenesulfonamide;methane;1-[6-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)pyrazin-2-yl]pyrrolidin-2-one;5-methyl-3-[6-[(1-methylazetidin-3-yl)methyl]pyrazin-2-yl]-7H-cyclopenta[b]pyridine;5-methyl-3-(3-pyrrolidin-1-ylpyrazin-2-yl)-7H-cyclopenta[b]pyridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-pyrrolo[3,4-b]pyridine
CID 152855482
4-[6-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)pyrazin-2-yl]morpholine;2-[4-[6-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)pyrazin-2-yl]piperazin-1-yl]ethanol;N-methyl-6-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-N-(oxan-4-ylmethyl)pyrazin-2-amine;5-methyl-3-[6-(4-methylpiperazin-1-yl)pyrazin-2-yl]-7H-cyclopenta[b]pyridine;5-methyl-3-[6-[(1-methylpiperidin-4-yl)methyl]pyrazin-2-yl]-7H-cyclopenta[b]pyridine;5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-7H-cyclopenta[b]pyridine
CID 159617564
3-[3-[3-(dimethylsulfamoyl)phenyl]pyrazin-2-yl]-N,N-dimethylbenzenesulfonamide
CID 13203487
N-[[6-(3,4-dihydro-2H-quinolin-1-yl)pyrazin-2-yl]methyl]ethanamine
CID 66456379
1-[4-[(6-phenylpyrazin-2-yl)methyl]piperidin-1-yl]ethanone
CID 95820935
1-[3-[(6-phenylpyrazin-2-yl)methyl]piperidin-1-yl]ethanone
CID 110255816
1-(2-methyl-6-piperidin-1-ylpyrimidin-4-yl)-2,3-dihydroindole
CID 112868870
1-[4-(4-methyl-2-piperidin-1-ylpyrimidin-5-yl)pyrimidin-2-yl]-2,3-dihydroindole
CID 25251781
3-[3-(dimethylsulfamoyl)phenyl]pyridine-2-carboxylic acid
CID 53224585
1-[1-(1-isoquinolin-1-ylazetidin-3-yl)pyrazol-4-yl]pyrrolidin-2-one
CID 126945315
N-[[3-[6-(2-oxopiperidin-1-yl)-3-pyridinyl]phenyl]methyl]methanesulfonamide
CID 154999229
3-bromo-N,N-dimethyl-4-(2-oxopyrrolidin-1-yl)benzenesulfonamide
CID 168940806

Frequently Asked Questions

What is the IUPAC name of 3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-cyclopenta[b]pyridine;N,N-dimethyl-3-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)benzenesulfonamide;methane;1-[6-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)pyrazin-2-yl]pyrrolidin-2-one;5-methyl-3-[6-[(1-methylazetidin-3-yl)methyl]pyrazin-2-yl]-7H-cyclopenta[b]pyridine;5-methyl-3-(3-pyrrolidin-1-ylpyrazin-2-yl)-7H-cyclopenta[b]pyridine?
The IUPAC name of 3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-cyclopenta[b]pyridine;N,N-dimethyl-3-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)benzenesulfonamide;methane;1-[6-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)pyrazin-2-yl]pyrrolidin-2-one;5-methyl-3-[6-[(1-methylazetidin-3-yl)methyl]pyrazin-2-yl]-7H-cyclopenta[b]pyridine;5-methyl-3-(3-pyrrolidin-1-ylpyrazin-2-yl)-7H-cyclopenta[b]pyridine (CID 158465638) is 3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-cyclopenta[b]pyridine;N,N-dimethyl-3-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)benzenesulfonamide;methane;1-[6-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)pyrazin-2-yl]pyrrolidin-2-one;5-methyl-3-[6-[(1-methylazetidin-3-yl)methyl]pyrazin-2-yl]-7H-cyclopenta[b]pyridine;5-methyl-3-(3-pyrrolidin-1-ylpyrazin-2-yl)-7H-cyclopenta[b]pyridine.
What is the SMILES notation for 3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-cyclopenta[b]pyridine;N,N-dimethyl-3-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)benzenesulfonamide;methane;1-[6-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)pyrazin-2-yl]pyrrolidin-2-one;5-methyl-3-[6-[(1-methylazetidin-3-yl)methyl]pyrazin-2-yl]-7H-cyclopenta[b]pyridine;5-methyl-3-(3-pyrrolidin-1-ylpyrazin-2-yl)-7H-cyclopenta[b]pyridine?
The canonical SMILES for 3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-cyclopenta[b]pyridine;N,N-dimethyl-3-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)benzenesulfonamide;methane;1-[6-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)pyrazin-2-yl]pyrrolidin-2-one;5-methyl-3-[6-[(1-methylazetidin-3-yl)methyl]pyrazin-2-yl]-7H-cyclopenta[b]pyridine;5-methyl-3-(3-pyrrolidin-1-ylpyrazin-2-yl)-7H-cyclopenta[b]pyridine is C.C.CC1=CCc2ncc(-c3cccc(S(=O)(=O)N(C)C)c3)cc21.CC1=CCc2ncc(-c3cncc(CC4CN(C)C4)n3)cc21.CC1=CCc2ncc(-c3cncc(N4CCCC4=O)n3)cc21.CC1=CCc2ncc(-c3cncc(N4CCc5ccccc54)n3)cc21.CC1=CCc2ncc(-c3nccnc3N3CCCC3)cc21.
What is the InChIKey of 3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-cyclopenta[b]pyridine;N,N-dimethyl-3-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)benzenesulfonamide;methane;1-[6-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)pyrazin-2-yl]pyrrolidin-2-one;5-methyl-3-[6-[(1-methylazetidin-3-yl)methyl]pyrazin-2-yl]-7H-cyclopenta[b]pyridine;5-methyl-3-(3-pyrrolidin-1-ylpyrazin-2-yl)-7H-cyclopenta[b]pyridine?
The InChIKey is HFSHSDBNAGWAPJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H18N4.C18H20N4.C17H16N4O.C17H18N4.C17H18N2O2S.2CH4/c1-14-6-7-18-17(14)10-16(11-23-18)19-12-22-13-21(24-19)25-9-8-15-4-2-3-5-20(15)25;1-12-3-4-17-16(12)6-14(7-20-17)18-9-19-8-15(21-18)5-13-10-22(2)11-13;1-11-4-5-14-13(11)7-12(8-19-14)15-9-18-10-16(20-15)21-6-2-3-17(21)22;1-12-4-5-15-14(12)10-13(11-20-15)16-17(19-7-6-18-16)21-8-2-3-9-21;1-12-7-8-17-16(12)10-14(11-18-17)13-5-4-6-15(9-13)22(20,21)19(2)3;;/h2-6,10-13H,7-9H2,1H3;3,6-9,13H,4-5,10-11H2,1-2H3;4,7-10H,2-3,5-6H2,1H3;4,6-7,10-11H,2-3,5,8-9H2,1H3;4-7,9-11H,8H2,1-3H3;2*1H4.
What are the key properties of 3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-cyclopenta[b]pyridine;N,N-dimethyl-3-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)benzenesulfonamide;methane;1-[6-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)pyrazin-2-yl]pyrrolidin-2-one;5-methyl-3-[6-[(1-methylazetidin-3-yl)methyl]pyrazin-2-yl]-7H-cyclopenta[b]pyridine;5-methyl-3-(3-pyrrolidin-1-ylpyrazin-2-yl)-7H-cyclopenta[b]pyridine?
3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-cyclopenta[b]pyridine;N,N-dimethyl-3-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)benzenesulfonamide;methane;1-[6-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)pyrazin-2-yl]pyrrolidin-2-one;5-methyl-3-[6-[(1-methylazetidin-3-yl)methyl]pyrazin-2-yl]-7H-cyclopenta[b]pyridine;5-methyl-3-(3-pyrrolidin-1-ylpyrazin-2-yl)-7H-cyclopenta[b]pyridine has a molecular weight of 1535.99 g/mol, XLogP of 16.75, 12 rotatable bonds, 0 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-cyclopenta[b]pyridine;N,N-dimethyl-3-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)benzenesulfonamide;methane;1-[6-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)pyrazin-2-yl]pyrrolidin-2-one;5-methyl-3-[6-[(1-methylazetidin-3-yl)methyl]pyrazin-2-yl]-7H-cyclopenta[b]pyridine;5-methyl-3-(3-pyrrolidin-1-ylpyrazin-2-yl)-7H-cyclopenta[b]pyridine is sourced from PubChem (CID 158465638), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).